Naseem Amin

Insider Reports History

Entity
Individual
Location
53 Frontage Road, Suite 301, Hampton, NJ
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naseem Amin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. Director Common Stock 292K $30.3K $0.10 Jun 7, 2023 Direct
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 11K Jul 30, 2024 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11K Jul 30, 2024 Direct

Insider Reports Filed by Naseem Amin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Jul 30, 2024 2 $0 4 Aug 1, 2024 Director
AVDL AVADEL PHARMACEUTICALS PLC May 17, 2024 1 $0 4 May 21, 2024 Director
AVDL AVADEL PHARMACEUTICALS PLC May 17, 2024 0 $0 3 May 21, 2024 Director
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Feb 10, 2023 1 $0 4 Feb 14, 2023 Director
BLPH Bellerophon Therapeutics, Inc. Dec 31, 2021 2 $26.9K 4 Jan 4, 2022 Director